IL1B and neurodegenerative disease: Conversely, inflammation has been increasingly demonstrated to contribute to the development of degenerative changes in the CNS, whereas subsequent increases in the levels of inflammatory cytokines, such as IL-1β and TNF-α, have been proposed to be pathological drivers of neurodegenerative diseases [1,5].